Neurophysiological biomarkers for Lewy body dementias
•Biomarkers are needed to improve Lewy body dementia (LBD) diagnosis and measure treatment response.•There is substantial heterogeneity in neurophysiology biomarker methodologies limiting comparison.•However, there is tentative evidence to suggest neurophysiological approaches may show promise as po...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Elsevier
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727506/ |